Gabapentin and Vertigo aggravated - a phase IV clinical study of FDA data
We study 292,819 people who have side effects when taking Gabapentin. Vertigo aggravated is found, especially among people who are female, 60+ old, have been taking the drug for < 1 month, also take Vitamin d3 and have Multiple sclerosis.
The phase IV clinical study analyzes which people take Gabapentin and have Vertigo aggravated. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
292,819 people reported to have side effects when taking Gabapentin.
Among them, 15,064 people (5.14%) have Vertigo aggravated.
What is Gabapentin?
Gabapentin has active ingredients of gabapentin. It is used in neuralgia. Currently, eHealthMe is studying from 302,007 Gabapentin users.
What is Vertigo aggravated?
Vertigo aggravated is found to be associated with 1,858 drugs and 637 conditions by eHealthMe. Currently, we are studying 130 people who have Vertigo aggravated.
Number of Gabapentin and Vertigo aggravated reports submitted per year:
Time on Gabapentin when people have Vertigo aggravated *:
Gender of people who have Vertigo aggravated when taking Gabapentin*:
Age of people who have Vertigo aggravated when taking Gabapentin *:
Common drugs people take besides Gabapentin *:
Common side effects people have besides Vertigo aggravated *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Gabapentin and have Vertigo aggravated?Check whether Vertigo aggravated is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
Gabapentin side effects by duration, gender and age:
- Gabapentin side effects (302,007 reports)
Vertigo aggravated treatments and more:
- Vertigo aggravated (130 reports)
Common drugs associated with Vertigo aggravated:
- Aspirin: 28,474 reports
- Prednisone: 20,995 reports
- Metformin: 17,586 reports
- Humira: 16,667 reports
- Omeprazole: 15,725 reports
- Amlodipine: 15,285 reports
- Gabapentin: 15,064 reports
- Lyrica: 14,707 reports
- Lisinopril: 14,554 reports
- Cymbalta: 13,318 reports
All the drugs that are associated with Vertigo aggravated:
- Vertigo aggravated (1,858 drugs)
Common conditions associated with Vertigo aggravated:
- High blood pressure: 30,116 reports
- Multiple sclerosis: 27,124 reports
- Depression: 21,440 reports
- Rheumatoid arthritis: 21,137 reports
- Pain: 17,817 reports
- Osteoporosis: 14,504 reports
All the conditions that are associated with Vertigo aggravated:
- Vertigo aggravated (637 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on gabapentin (the active ingredients of Gabapentin) and Gabapentin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Maxalt and Sudafed drug interaction - 15 seconds ago
- Prozac and Headache - 15 seconds ago
- Singulair and Bladder Mass - 16 seconds ago
- Ceftriaxone Sodium and Aldurazyme drug interaction - 22 seconds ago
- Linagliptin and Latanoprost drug interaction - 54 seconds ago
- Guaifenesin and Iron Deficiency Anaemia - a minute ago
- Benicar Hct and Blood Potassium Decreased - a minute ago
- Famotidine and Flomax drug interaction - a minute ago
- Methotrexate and Azelaic Acid drug interaction - a minute ago
- Trichlormethiazide and Speech Impairment (Adult) - a minute ago